Académique Documents
Professionnel Documents
Culture Documents
ACETYLCHOLINE
NERVE IMPULSE
ACETYLCHOLINE
MYONEURAL JUNCTION
JUNCTIONAL CLEFT
DEPOLARIZATION
Ca++ enters nerve terminal
Synthesis
Acetylcholine is synthezised in
Axoplasm of nerve terminal from
Choline obtained from E.C.F
And transferred to vesicles ready
For use
Hydrolysis
Pharmacokinetics
Non depolarizers
Poorly bound to plasma protein
Eliminated unchanged by the liver excepting atracurium,
and to a smaller extent by gall bladder
Biliary excretion increase in renal failure
The drugs are concentrated in the liver, kidney, cartilage
Early hepatic uptake lowers plasma concentratic of these
drugs except gallamin & atracurium
These pharmacokinetics are altered in liver disease,
increasing terminal elimination half time by about 50%
Pharmacodynamics
Effects on motor end plate
Preventing absorbsion of acetylcholine to
cholinergic receptors prevent the changes
in the end plate which cause muscular tone
and contraction
Effects on respiration
Cause paralysis of muscle of respiration
Causing square wave respiration
The diaphragm being less sensitive than other
is the last one to be paralysed
Effects on circulation
Turbocurarine
Pancuronium
Tachycardia
Skin flushing
:Hypotension
:Hypertension
:Gallamine
: Atracurium
Allergic effect
Any of these drugs may cause histamine release at the first
injection
Turbocurarine
:The most likely
Vercuronium
:The least likely
A second injection in the same day will not do so (owing to the
great rapidity which histamine release develops tachyphylaxis)
Vercuronium
Atracurium
2. Hepatic failure
Atracurium
3. Mysthenia Gravis
Pancuronium
Turbocurarine
6. Obstetrics
7. Short cases
Atracurium
8. Crash induction
Alcuronium
Vercuronium
Management of incomplete
reversal
IPPV is given with a mask an oxygen while the
degree of incomplete reversal is assesed
If mild (T4/T1 ratio >50%, respiration is almost
adequate, more neostigmine or other
anticholinesterase is given
If severe (T4/T1 ratio <50%, respiration is
obviously in adequate) the patient is sedated
(e.g with diazepam), intubated and IPPV
continued with a ventilator for at least an hour,
acid base balance determined and corrected
serum electrolyte estimated and normalized re
assesment using nerve stimulators
Non depolarizers
Rapid onset
Short duration of action
Rapid recovery
Non cummulative
No cardiovascular side effects
No histamine release
Reversible
High potency
Pharmacological inactive metabolites
Muscle facilitation
Post operative muscle pain
Hyperkalemia
Increased intra ocular pressure
Increased intra gastric pressure
Increased intra cranial pressure
Cardiovascular effects
Hyperkalemia in succynylcholin
Massive burns especially in children
Massive muscle trauma
Lower motor neuron disease &
denervation of motor nerves
E.G : Guillain Barre Syndrome
Acute spinal cord comression
Rapid onset of demyelinating disease of
the motor nerves and other neuropathies
Over dose
More than 1 G in an infusion
Tachyphylaxis may occur
Hypocapnia
Respiration will reccomence if blood level is allowed to rise
Unlikely in practice can cause ventricular fibrillation
Hypercapnia
Unlikely in practice can cause ventricular fibrillation
Metabolic acidosis
Mechanism not understood
Ganglionic blockade
Blockade of cardiac muscarinic receptors
Nor adrenalin
Stimulation of nor adrenalin release
Histamin release
Depolarizers
Rapid onset
% receptor still
occupied
Nerve
stimulator
Tidal volume
75-80
Sustain T 30
70-75
Normal TOF
Inspiratory force 50
Sustain T 100
Sustain T 200